Patients Already in Biohaven Epilepsy Trials Keep Dosing as FDA Pauses New Enrollment Over a Rodent FindingWorldNewsHub24September 11, 2026 The Food and Drug Administration has paused new patient enrollment in trials of opakalim, an experimental epilepsy drug also known…
Health Phase 3 Clinical Trial Success for Smart Watch Epilepsy AppWorldNewsHub24June 22, 2026 May 2026, Johns Hopkins School of Medicine, MD, USA neurologists announced in the journal Neurology Open Access that the EpiWatch…
